Conclusions All interventions produced positive effects on BMD scanning and osteoporosis treatment rates post-fracture .
Despite sizeable increases , investigation and treatment rates remain sub-optimal .
Background There is a large quality of care gap for patients with osteoporosis .
As a fragility fracture is a strong indicator of underlying osteoporosis , it offers an ideal opportunity to initiate investigation and treatment .
However , studies of post-fracture population s document screening and treatment rates below 20 % in most setting s. This is despite the fact that bone mineral density ( BMD ) scans are effective at identifying patients at high risk of fracture , and effective drug treatments are widely available .
Effective interventions are required to remedy this incongruity in current practice .
Appendicular bone mineral and a woman's lifetime risk of hip fracture.
Appendicular bone mass is inversely related to the risk of hip fracture  in short-term prospect i ve studies , but hip fractures typically occur about 30 years after menopause . We developed a model that estimates a woman 's lifetime risk of hip fracture  based on measurement of radial bone mass at age 50  using short-term prospect i ve data relating bone mass to hip fracture , the correlation between bone mass at age 50 and later years , the age-specific incidence of hip fracture and mortality , and prospect i ve data about bone mass and mortality . We estimate that a 50-year-old white woman has a 19 % lifetime risk of hip fracture if her radial bone mass is at the 10th percentile for her age and an 11 % lifetime risk if her bone mass is at the 90th percentile . Improved measurement techniques that have a higher predictive value for hip fracture in short-term studies could substantially increase this gradient of lifetime risk and therefore be more clinical ly useful
Conclusions All interventions produced positive effects on BMD scanning and osteoporosis treatment rates post-fracture .
Despite sizeable increases , investigation and treatment rates remain sub-optimal .
Background There is a large quality of care gap for patients with osteoporosis .
As a fragility fracture is a strong indicator of underlying osteoporosis , it offers an ideal opportunity to initiate investigation and treatment .
However , studies of post-fracture population s document screening and treatment rates below 20 % in most setting s. This is despite the fact that bone mineral density ( BMD ) scans are effective at identifying patients at high risk of fracture , and effective drug treatments are widely available .
Effective interventions are required to remedy this incongruity in current practice .